Bluejay Diagnostics logo

Bluejay Diagnostics

BJDX | NASDAQ
Chart Builder DCF Calculator
$2.29
-$0.32 (-12.26%)
At close: Nov 16, 2026, 4:00 PM ET
$2.29
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-12.26%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.2
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #703/1021 (Top 69%)

Key Statistics

Market Data

Market Cap $2.56M
1D Range
2.26 2.68
52W Range
2.12 23.20

Valuation (TTM)

PE -0.10
PB 0.34
EV/EBITDA 0.64

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of...

Sector Healthcare
Employees 6
IPO Date Nov 10, 2021
Fiscal Year January - December

Latest News

Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients

1 month ago · benzinga.com

Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

2 months ago · globenewswire.com

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

3 months ago · globenewswire.com

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.